Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Innovating for Growth


Published on

Presentation to ERC State of Small Business Britain Conference 2017 by Emma Sceats .

Published in: Business
  • Hello! I can recommend a site that has helped me. It's called ⇒ ⇐ They helped me for writing my quality research paper.
    Are you sure you want to  Yes  No
    Your message goes here
  • Be the first to like this

Innovating for Growth

  1. 1. Innovating for Growth Dr Emma Sceats, Chief Executive, CN Bio Innovations London, September 7th 2017
  3. 3. 3 OUR Vision To be the world leader in precision biology replacing animal testing with accurate, human relevant technologies
  4. 4. 4 $26m DARPA contract with the Massachusetts Institute of Technology a Human-on-a-Chip?
  5. 5. 5 Benefits Intellectual Property IP Pipeline CN Bio secured exclusive rights to commercialise all IP arising from the MIT-led DARPA consortium’s research to develop a human body-on-a-chip. Team Recruiting new skills DARPA grant enabled CN Bio to hire new team members bringing specialist biology and engineering skills into our business. Expert Collaborators MIT Professor Linda Griffith Professor of Biological & Mechanical engineering. Lead PI on $26M DARPA contract. US National Academy of Engineers. Recipient of MacArthur “Genius” Fellowship.
  6. 6. 6 “Ensuring that Britain remains attractive for inward investment will surely help more companies like ours access the funding needed for growth” E. Sceats
  7. 7. 7
  8. 8. 8 Customers (early adopters) Federal Grants & Contracts Exports Knowledge / IP $$$ - Talent - Customers - Collaborators - Grants
  9. 9. 9 “As small companies endeavour to become large and internationally successful businesses understanding the challenges and trade-offs these businesses face will be crucial for developing policies that will nurture home- grown talent” E. Sceats
  10. 10. 10 Ecosystem TWO global Big Pharma companies (AZ, GSK) headquartered in UK Thriving biotech sector from large, international players (e.g. Shire) to university spin-outs World-class medical devices sector employing >50,000 staff UK life sciences sector employs >233,000 people, generating £64bn revenue each year #1 destination for foreign direct investment in Europe
  11. 11. 11 “It will be exciting to see how implementation of Sir John Bell’s recommendations can be a catalyst for growth, both for our company and our country” E. Sceats
  12. 12. 12 Thank You